Connect with us

Investigation

CBG: a promising biomarker to detect recent cannabis use

Published

em

Photo: DR

A groundbreaking study published in the journal Clinical Toxicology revealed an innovative approach to cannabis detection: the use of Cannabigerol (CBG) as a biomarker to identify recent cannabis use. Unlike other cannabinoids, CBG, a minor cannabinoid, emerges as an effective indicator of recent cannabis use. This discovery could help clarify forensic investigations and understand whether there has been recent use of cannabis in scenarios such as car accidents or workplace incidents, where detecting cannabis intoxication can be crucial.

In a comprehensive investigation conducted by Denver Health and Colorado University, 56 individuals participated, of which 32 were daily cannabis consumers and 24 were occasional consumers. Each participant consumed cannabis as they normally would, with blood samples taken immediately before and 30 minutes after consumption. The results were surprising: CBG was detected in 28 participants after smoking, highlighting its potential as an indicator of recent cannabis use.

CBG vs. THC: The crucial distinction

The importance lies in the unique characteristics of CBG. Unlike THC, the main psychoactive compound in cannabis, CBG dissipates quickly from the bloodstream. This fleeting presence makes CBG an ideal marker for recent cannabis use, especially in scenarios such as car accidents or workplace incidents, where detection of active cannabis intoxication is crucial.

Accuracy of CBG as a Biomarker

O study established that a whole blood CBG concentration equal to or greater than 0,2 milligrams per liter (mg/L) had 96% specificity, 50% sensitivity and 73% accuracy in identifying cannabis consumption in the last 30 minutes. Although CBG proves to be highly specific but less sensitive, it serves as a valuable complement to other cannabinoids in blood in forensic investigations.

Challenges and future perspectives: Beyond THC

However, challenges to these findings remain. The study did not measure the exact amount of CBG present in the cannabis consumed, which limits accurate correlations. Furthermore, the time period for collecting blood samples may not correspond to real-life forensic situations and the effects of cannabis can still vary greatly from person to person. However, ongoing research explores the behaviors of various cannabinoids in the body after cannabis consumption, paving the way for a more comprehensive understanding of cannabis detection.

Unlike alcohol detection, cannabis intoxication poses complex challenges. THC, which remains in the body for weeks after use, complicates accurate detection. Study investigators are actively researching the pharmacokinetics of various cannabinoids following inhalation, with the goal of identifying additional biomarkers for cannabis use. Furthermore, as the market for broad-spectrum CBD products expands, it becomes imperative to consider their impact on blood cannabinoid levels, which increases the complexity of methods for detecting cannabis use.

In conclusion, this pioneering study lights the way to a more nuanced and accurate cannabis detection system. With the emergence of CBG as a promising biomarker, the future of detecting recent cannabis use is clearer than ever, promising safer roads and workplaces for everyone.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

More posts

With a professional background in CAD technical drawing (2D and 3D), João Xabregas is an activist and advocate for all uses and applications of cannabis. He discovered and entered the world of cannabis during his youth, where he developed a special interest in the cultivation of the plant, which led him on a journey of self-learning through the world of cannabis that continues to this day. His adventures linked to cannabis cultivation began with the same goal as many others: to be able to guarantee the quality and eliminate any possible risks to his health of what he consumed, as well as to avoid any type of dependence on the illicit market. However, he quickly began to view the world of cannabis and everything related to it with a very different perspective. He admits the enormous passion he has for the most persecuted plant in the world and about which he is always willing to write and have a good conversation.

Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertise with us!


Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

International2 days ago

Farewell to the Spanish Observatory of Medicinal Cannabis

After a decade of fighting for fairer policies for patients who need access to cannabis in...

International3 days ago

President of Infarmed, Rui Santos Ivo, elected President of the Board of Directors of EMA

Rui Santos Ivo, president of the National Authority for Medicines and Health Products IP (Infarmed), was elected president of the Board...

Science3 days ago

Review of studies reveals the importance of the Endocannabinoid System in gastrointestinal diseases

A comprehensive review of studies published in the International Journal of Molecular Sciences analyzed the influence of the endocannabinoid system (ECS) on...

Hemp3 days ago

EXCLUSIVE: European Union clarifies that hemp-derived CBD is permitted in cosmetics

The European Commission has responded to a request for clarification from CannaReporter® on the recent decision by Infarmed IP to withdraw from...

International4 days ago

HHC Classified as “Schedule II” by the Commission on Narcotic Drugs and Drug Enforcement

At its session held today in Vienna, the United Nations Commission on Psychotropic Substances (CND) approved, by qualified majority, the...

National5 days ago

Portugal: Government falls for the third time in three years and legalization of cannabis becomes increasingly difficult

Portugal's center-right government, led by Prime Minister Luis Montenegro of the PSD (Social Democratic Party) collapsed today after the...

Interviews1 weeks ago

Alan Dronkers: “HempFlax is producing the cleanest fibre in Europe (…) but it needs to move to the next level”

Few names carry as much weight in the world of hemp and cannabis as the Dronkers family. Since their...

Science1 weeks ago

Over the last ten years, more than 35 scientific articles on cannabis have been published

An analysis by the National Organization for the Reform of Marijuana Laws (NORML) in the US reveals that the open file...

Science1 weeks ago

Hexahydrocannabinol (HHC): all about its chemistry, pharmacology, effects and safety

Hexahydrocannabinol (HHC) is rapidly emerging as one of the most discussed cannabinoids in the growing world of cannabis-derived compounds.

Events1 weeks ago

Spannabis bids farewell to Barcelona and moves to Bilbao in 2026

Known as Europe's largest and oldest cannabis trade fair and exhibition, Spannabis, which is...